Endo International plc. (ENDP) NASDAQ
$0.29 0 (0.00%)
Market Cap: $0
As of 08/25/22 12:00 AM EDT. Market closed.
Endo International plc. (ENDP)
NASDAQ
$0.29
0 (0.00%)
Market Cap: $0
As of 08/25/22 12:00 AM EDT. Market closed.
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need ... read more
Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$913,462
CEO Compensation (Total)
$19.97M
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
3,397
CEO Compensation (Base)
$913,462
CEO Compensation (Total)
$19.97M
URL
Address
.
PRICE CHART FOR ENDO INTERNATIONAL PLC
From:
To:
NEWS
KEY STATS
Open
$0.30
Previous Close
$0.29
Days Range
$0.28 - $0.31
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
235,142,889
Open
$0.30
Previous Close
$0.29
Days Range
$0.28 - $0.31
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
235,142,889
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ENDO INTERNATIONAL PLC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Mar 29, 2022 | Option Exercise | $2.52 | 4,141 | 10,435 | 157,729 | Mar 31, 2022, 04:09 PM |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Mar 30, 2022 | Option Exercise | $2.52 | 4,975 | 12,537 | 169,711 | Mar 31, 2022, 04:09 PM |
| Raciti Frank B. | VP, Controller and CAO | Mar 29, 2022 | Option Exercise | $2.52 | 965 | 2,432 | 8,821 | Mar 31, 2022, 04:08 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Mar 30, 2022 | Option Exercise | $2.52 | 10,179 | 25,651 | 351,085 | Mar 31, 2022, 04:06 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Mar 29, 2022 | Option Exercise | $2.52 | 8,472 | 21,349 | 326,850 | Mar 31, 2022, 04:06 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Mar 30, 2022 | Option Exercise | $2.52 | 3,057 | 7,704 | 101,477 | Mar 31, 2022, 04:03 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Mar 29, 2022 | Option Exercise | $2.52 | 2,544 | 6,411 | 93,799 | Mar 31, 2022, 04:03 PM |
| Coleman Blaise | President, CEO | Mar 30, 2022 | Option Exercise | $2.52 | 10,137 | 25,545 | 422,066 | Mar 31, 2022, 04:02 PM |
| Coleman Blaise | President, CEO | Mar 29, 2022 | Option Exercise | $2.52 | 8,437 | 21,261 | 396,293 | Mar 31, 2022, 04:02 PM |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Mar 05, 2022 | Option Exercise | $2.34 | 7,853 | 18,396 | 147,757 | Mar 08, 2022, 04:07 PM |
| Raciti Frank B. | VP, Controller and CAO | Mar 05, 2022 | Option Exercise | $2.34 | 394 | 923 | 6,927 | Mar 08, 2022, 04:05 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Mar 05, 2022 | Option Exercise | $2.34 | 9,120 | 21,364 | 306,680 | Mar 08, 2022, 04:01 PM |
| Smith Mary Christine | Director | Jun 11, 2021 | Option Exercise | $6.26 | 25,073 | 156,957 | 32,819 | Jun 15, 2021, 04:04 PM |
| Barberio Mark G | Director | Jun 11, 2021 | Option Exercise | $6.26 | 23,003 | 143,999 | 38,187 | Jun 15, 2021, 04:03 PM |
| MONTAGUE WILLIAM P | Director | Jun 11, 2021 | Option Exercise | $6.26 | 23,003 | 143,999 | 112,025 | Jun 15, 2021, 04:01 PM |
| Apostol George | EVP, Global R&D | Jun 01, 2021 | Option Exercise | $5.97 | 7,940 | 47,362 | 7,331 | Jun 03, 2021, 04:03 PM |
| Boyle Jack D. | SVP, Controller | Apr 06, 2021 | Option Exercise | $7.37 | 3,727 | 27,468 | 59,868 | Apr 06, 2021, 05:01 PM |
| Boyle Jack D. | SVP, Controller | Apr 02, 2021 | Option Exercise | $7.37 | 3,036 | 22,375 | 50,941 | Apr 06, 2021, 05:01 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Apr 06, 2021 | Option Exercise | $7.37 | 29,735 | 219,147 | 287,903 | Apr 06, 2021, 04:49 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Apr 02, 2021 | Option Exercise | $7.37 | 24,221 | 178,509 | 250,653 | Apr 06, 2021, 04:49 PM |
| Campanelli Paul | Director | Apr 06, 2021 | Option Exercise | $7.37 | 188,384 | 1,388,390 | 1,607,550 | Apr 06, 2021, 04:46 PM |
| Campanelli Paul | Director | Apr 02, 2021 | Option Exercise | $7.37 | 146,400 | 1,078,968 | 1,427,634 | Apr 06, 2021, 04:46 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Mar 29, 2021 | Option Exercise | $7.31 | 2,544 | 18,604 | 42,742 | Mar 31, 2021, 04:08 PM |
| Campanelli Paul | Director | Mar 29, 2021 | Option Exercise | $7.31 | 72,926 | 533,301 | 1,274,034 | Mar 31, 2021, 04:07 PM |
| Boyle Jack D. | SVP, Controller | Mar 29, 2021 | Option Exercise | $7.31 | 2,978 | 21,778 | 43,669 | Mar 31, 2021, 04:06 PM |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Mar 29, 2021 | Option Exercise | $7.31 | 6,229 | 45,552 | 103,027 | Mar 31, 2021, 04:04 PM |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | Mar 29, 2021 | Option Exercise | $7.31 | 12,714 | 92,976 | 220,311 | Mar 31, 2021, 04:03 PM |
| Coleman Blaise | President, CEO | Mar 29, 2021 | Option Exercise | $7.31 | 12,920 | 94,483 | 224,466 | Mar 31, 2021, 04:02 PM |
| MONTAGUE WILLIAM P | Director | Mar 15, 2021 | Sale | $8.68 | 9,033 | 78,406 | 97,104 | Mar 16, 2021, 04:01 PM |
| Cooke Shane | Director | Mar 15, 2021 | Sale | $8.65 | 17,290 | 149,558 | 77,030 | Mar 15, 2021, 04:36 PM |
| Smith Mary Christine | Director | Jul 29, 2020 | Option Exercise | $3.43 | 5,219 | 17,901 | 5,655 | Sep 24, 2020, 04:20 PM |
| Ciarico Domenico | EVP & Chief Commercial Officer | Sep 03, 2020 | Option Exercise | $2.91 | 19,187 | 55,834 | 55,958 | Sep 08, 2020, 04:05 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Aug 10, 2020 | Option Exercise | $3.40 | 16,511 | 56,137 | 204,383 | Aug 12, 2020, 04:20 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Aug 10, 2020 | Option Exercise | $3.33 | 3,770 | 12,554 | 55,244 | Aug 12, 2020, 04:18 PM |
| Boyle Jack D. | SVP, Controller | Aug 10, 2020 | Option Exercise | $3.40 | 684 | 2,326 | 36,538 | Aug 12, 2020, 04:17 PM |
| Coleman Blaise | President, CEO | Aug 10, 2020 | Option Exercise | $3.40 | 16,511 | 56,137 | 207,498 | Aug 12, 2020, 04:14 PM |
| Campanelli Paul | Director | Aug 10, 2020 | Option Exercise | $3.40 | 116,789 | 397,083 | 1,197,521 | Aug 12, 2020, 04:13 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Aug 10, 2020 | Option Exercise | $3.40 | 1,372 | 4,665 | 36,351 | Aug 12, 2020, 04:11 PM |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Aug 10, 2020 | Option Exercise | $3.40 | 5,435 | 18,479 | 95,142 | Aug 12, 2020, 04:10 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Aug 10, 2020 | Option Exercise | $3.40 | 18,363 | 62,434 | 356,644 | Aug 12, 2020, 04:08 PM |
| Ciarico Domenico | EVP & Chief Commercial Officer | Aug 01, 2020 | Option Exercise | $3.39 | 2,977 | 10,092 | 19,122 | Aug 03, 2020, 04:05 PM |
| Smith Mary Christine | Director | Jul 29, 2020 | Option Exercise | $3.43 | 10,438 | 35,802 | 11,309 | Jul 30, 2020, 07:18 PM |
| Smith Mary Christine | Director | Jul 29, 2020 | Option Exercise | $3.43 | 10,438 | 35,802 | 11,309 | Jul 30, 2020, 06:54 PM |
| Cooke Shane | Director | Jun 12, 2020 | Option Exercise | $3.43 | 13,265 | 45,499 | 94,320 | Jun 16, 2020, 04:14 PM |
| Barberio Mark G | Director | Jun 12, 2020 | Option Exercise | $3.43 | 12,245 | 42,000 | 13,266 | Jun 16, 2020, 04:13 PM |
| MONTAGUE WILLIAM P | Director | Jun 12, 2020 | Option Exercise | $3.43 | 12,245 | 42,000 | 106,137 | Jun 16, 2020, 04:11 PM |
| KIMMEL ROGER H | Director | Jun 12, 2020 | Option Exercise | $3.43 | 12,245 | 42,000 | 136,575 | Jun 16, 2020, 04:09 PM |
| HYATT MICHAEL | Director | Jun 12, 2020 | Option Exercise | $3.43 | 12,245 | 42,000 | 320,264 | Jun 16, 2020, 04:08 PM |
| Hutson Nancy J | Director | Jun 12, 2020 | Option Exercise | $3.43 | 12,245 | 42,000 | 91,219 | Jun 16, 2020, 04:06 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Apr 02, 2020 | Option Exercise | $3.16 | 6,154 | 19,447 | 32,862 | Apr 06, 2020, 04:16 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Apr 02, 2020 | Option Exercise | $3.16 | 24,432 | 77,205 | 182,700 | Apr 06, 2020, 04:13 PM |
| Coleman Blaise | President, CEO | Apr 02, 2020 | Option Exercise | $3.16 | 25,056 | 79,177 | 185,815 | Apr 06, 2020, 04:11 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Apr 02, 2020 | Option Exercise | $3.09 | 9,329 | 28,827 | 50,991 | Apr 06, 2020, 04:10 PM |
| Barry Patrick A | EVP & Pres,Global Comm Ops | Apr 02, 2020 | Option Exercise | $3.16 | 6,936 | 21,918 | 88,077 | Apr 06, 2020, 04:08 PM |
| Boyle Jack D. | SVP, Controller | Apr 02, 2020 | Option Exercise | $3.16 | 3,036 | 9,594 | 34,817 | Apr 06, 2020, 04:06 PM |
| Campanelli Paul | Director | Apr 02, 2020 | Option Exercise | $3.16 | 146,400 | 462,624 | 1,074,985 | Apr 06, 2020, 04:04 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Apr 02, 2020 | Option Exercise | $3.16 | 34,978 | 110,530 | 337,507 | Apr 06, 2020, 04:03 PM |
| Coleman Blaise | President, CEO | Mar 29, 2020 | Option Exercise | $3.52 | 13,725 | 48,312 | 156,308 | Mar 31, 2020, 04:24 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Mar 29, 2020 | Option Exercise | $3.52 | 12,826 | 45,148 | 152,569 | Mar 31, 2020, 04:21 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Mar 29, 2020 | Option Exercise | $3.52 | 4,112 | 14,474 | 71,204 | Mar 31, 2020, 04:17 PM |
| Campanelli Paul | Director | Mar 29, 2020 | Option Exercise | $3.52 | 72,926 | 256,700 | 921,385 | Mar 31, 2020, 04:15 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Mar 29, 2020 | Option Exercise | $3.47 | 4,214 | 14,623 | 40,470 | Mar 31, 2020, 04:14 PM |
| Bradley Mark T. | EVP, Chief Financial Officer | Mar 29, 2020 | Option Exercise | $3.52 | 2,639 | 9,289 | 18,183 | Mar 31, 2020, 04:12 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Mar 29, 2020 | Option Exercise | $3.52 | 17,786 | 62,607 | 301,057 | Mar 31, 2020, 04:10 PM |
| Ciarico Domenico | EVP & Chief Commercial Officer | Mar 29, 2020 | Option Exercise | $3.52 | 1,386 | 4,879 | 13,405 | Mar 31, 2020, 04:08 PM |
| Boyle Jack D. | SVP, Controller | Mar 29, 2020 | Option Exercise | $3.52 | 2,978 | 10,483 | 27,545 | Mar 31, 2020, 04:06 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 25, 2020 | Option Exercise | $6.19 | 8,579 | 53,104 | 140,145 | Feb 25, 2020, 04:44 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 23, 2020 | Option Exercise | $6.19 | 105 | 650 | 118,329 | Feb 25, 2020, 04:44 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 21, 2020 | Option Exercise | $6.19 | 3,121 | 19,319 | 118,059 | Feb 25, 2020, 04:44 PM |
| Campanelli Paul | President, CEO | Feb 25, 2020 | Option Exercise | $6.19 | 92,976 | 575,521 | 844,871 | Feb 25, 2020, 04:42 PM |
| Campanelli Paul | President, CEO | Feb 23, 2020 | Option Exercise | $6.19 | 998 | 6,178 | 729,417 | Feb 25, 2020, 04:42 PM |
| Campanelli Paul | President, CEO | Feb 21, 2020 | Option Exercise | $6.19 | 24,184 | 149,699 | 727,460 | Feb 25, 2020, 04:42 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 23, 2020 | Option Exercise | $6.19 | 792 | 4,902 | 256,467 | Feb 25, 2020, 04:40 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 21, 2020 | Option Exercise | $6.19 | 9,442 | 58,446 | 255,970 | Feb 25, 2020, 04:40 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 25, 2020 | Option Exercise | $6.19 | 26,053 | 161,268 | 282,521 | Feb 25, 2020, 04:40 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Feb 25, 2020 | Option Exercise | $6.07 | 4,569 | 27,734 | 35,716 | Feb 25, 2020, 04:39 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Feb 23, 2020 | Option Exercise | $6.07 | 165 | 1,002 | 30,559 | Feb 25, 2020, 04:39 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Feb 21, 2020 | Option Exercise | $6.07 | 1,662 | 10,088 | 30,371 | Feb 25, 2020, 04:39 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 25, 2020 | Option Exercise | $6.19 | 8,333 | 51,581 | 136,752 | Feb 25, 2020, 04:37 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 23, 2020 | Option Exercise | $6.19 | 400 | 2,476 | 115,558 | Feb 25, 2020, 04:37 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 21, 2020 | Option Exercise | $6.19 | 3,031 | 18,762 | 114,540 | Feb 25, 2020, 04:37 PM |
| Boyle Jack D. | SVP, Controller | Feb 25, 2020 | Option Exercise | $6.19 | 1,104 | 6,834 | 20,413 | Feb 25, 2020, 04:34 PM |
| Boyle Jack D. | SVP, Controller | Feb 23, 2020 | Option Exercise | $6.19 | 83 | 514 | 17,508 | Feb 25, 2020, 04:34 PM |
| Boyle Jack D. | SVP, Controller | Feb 21, 2020 | Option Exercise | $6.19 | 407 | 2,519 | 17,290 | Feb 25, 2020, 04:34 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Feb 25, 2020 | Option Exercise | $6.19 | 3,758 | 23,262 | 61,202 | Feb 25, 2020, 12:00 AM |
| Barry Patrick A | EVP & Chief Commercial Officer | Feb 21, 2020 | Option Exercise | $6.19 | 1,367 | 8,462 | 51,761 | Feb 25, 2020, 12:00 AM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Dec 31, 2019 | Option Exercise | $4.59 | 598 | 2,745 | 106,831 | Jan 03, 2020, 04:03 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Dec 01, 2019 | Option Exercise | $4.95 | 2,619 | 12,964 | 48,327 | Dec 03, 2019, 04:02 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Oct 01, 2019 | Option Exercise | $3.34 | 110 | 367 | 28,495 | Oct 03, 2019, 05:42 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Sep 28, 2019 | Option Exercise | $3.12 | 594 | 1,853 | 246,459 | Oct 01, 2019, 04:07 PM |
| Campanelli Paul | President, CEO | Sep 28, 2019 | Option Exercise | $3.12 | 1,874 | 5,847 | 675,829 | Oct 01, 2019, 04:05 PM |
| KIMMEL ROGER H | Director | Sep 16, 2019 | Sale | $4.09 | 30,000 | 122,700 | 80,000 | Sep 17, 2019, 05:23 PM |
| KIMMEL ROGER H | Director | Sep 16, 2019 | Sale | $4.09 | 25,000 | 102,250 | 123,309 | Sep 17, 2019, 05:23 PM |
| Nichol Carrie Ann | SVP, Controller & CAO | Aug 10, 2019 | Option Exercise | $2.49 | 484 | 1,205 | 14,096 | Aug 13, 2019, 05:52 PM |
| Garella Rahul | EVP, Intl Pharmaceuticals | Aug 10, 2019 | Option Exercise | $2.44 | 3,771 | 9,201 | 28,369 | Aug 13, 2019, 05:52 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Aug 10, 2019 | Option Exercise | $2.49 | 3,560 | 8,864 | 42,940 | Aug 13, 2019, 05:52 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Aug 10, 2019 | Option Exercise | $2.49 | 16,511 | 41,112 | 106,227 | Aug 13, 2019, 05:51 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Aug 10, 2019 | Option Exercise | $2.49 | 16,511 | 41,112 | 110,124 | Aug 13, 2019, 05:51 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Aug 10, 2019 | Option Exercise | $2.49 | 18,363 | 45,724 | 245,840 | Aug 13, 2019, 05:50 PM |
| Campanelli Paul | President, CEO | Aug 10, 2019 | Option Exercise | $2.49 | 116,790 | 290,807 | 673,862 | Aug 13, 2019, 05:50 PM |
| KIMMEL ROGER H | Director | Jun 17, 2019 | Sale | $3.93 | 10,000 | 39,300 | 110,000 | Jun 19, 2019, 04:01 PM |
| KIMMEL ROGER H | Director | Jun 17, 2019 | Sale | $3.93 | 24,951 | 98,057 | 148,309 | Jun 19, 2019, 04:01 PM |
| HYATT MICHAEL | Director | Jun 12, 2019 | Option Exercise | $4.46 | 25,829 | 115,197 | 306,998 | Jun 14, 2019, 07:35 PM |
| MONTAGUE WILLIAM P | Director | Jun 12, 2019 | Option Exercise | $4.46 | 25,829 | 115,197 | 92,871 | Jun 14, 2019, 07:33 PM |
| Mansukani Sharad | Director | Jun 12, 2019 | Option Exercise | $4.46 | 25,829 | 115,197 | 71,523 | Jun 14, 2019, 07:32 PM |
| KIMMEL ROGER H | Director | Jun 12, 2019 | Option Exercise | $4.46 | 25,829 | 115,197 | 173,260 | Jun 14, 2019, 07:32 PM |
| Hutson Nancy J | Director | Jun 12, 2019 | Option Exercise | $4.46 | 25,829 | 115,197 | 77,953 | Jun 14, 2019, 07:30 PM |
| Cooke Shane | Director | Jun 12, 2019 | Option Exercise | $4.46 | 27,982 | 124,800 | 82,074 | Jun 14, 2019, 07:29 PM |
| Nichol Carrie Ann | SVP, Controller & CAO | May 26, 2019 | Option Exercise | $6.02 | 237 | 1,427 | 12,879 | May 29, 2019, 04:01 PM |
| Coleman Blaise | EVP, Chief Financial Officer | May 16, 2019 | Option Exercise | $6.69 | 1,158 | 7,747 | 88,441 | May 20, 2019, 04:04 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Apr 29, 2019 | Option Exercise | $7.67 | 389 | 2,984 | 84,544 | May 01, 2019, 04:23 PM |
| Pera Antonio R | President, Par Pharmaceutical | Apr 02, 2019 | Option Exercise | $8.10 | 11,669 | 94,519 | 65,648 | Apr 04, 2019, 04:36 PM |
| Nichol Carrie Ann | SVP, Controller & CAO | Apr 02, 2019 | Option Exercise | $8.10 | 2,235 | 18,104 | 12,283 | Apr 04, 2019, 04:35 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Apr 02, 2019 | Option Exercise | $8.10 | 21,142 | 171,250 | 84,031 | Apr 04, 2019, 04:34 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Apr 02, 2019 | Option Exercise | $8.10 | 37,393 | 302,883 | 226,703 | Apr 04, 2019, 04:34 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Apr 02, 2019 | Option Exercise | $8.10 | 10,508 | 85,115 | 34,000 | Apr 04, 2019, 04:33 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Apr 02, 2019 | Option Exercise | $8.10 | 23,674 | 191,759 | 86,919 | Apr 04, 2019, 04:32 PM |
| Campanelli Paul | President, CEO | Apr 02, 2019 | Option Exercise | $8.10 | 146,400 | 1,185,840 | 551,326 | Apr 04, 2019, 04:31 PM |
| Pera Antonio R | President, Par Pharmaceutical | Feb 23, 2019 | Option Exercise | $10.51 | 186 | 1,955 | 40,809 | Feb 26, 2019, 05:35 PM |
| Nichol Carrie Ann | VP, Controller & CAO | Feb 23, 2019 | Option Exercise | $10.51 | 75 | 788 | 6,740 | Feb 26, 2019, 05:34 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 23, 2019 | Option Exercise | $10.51 | 400 | 4,204 | 50,609 | Feb 26, 2019, 05:34 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 23, 2019 | Option Exercise | $10.51 | 314 | 3,300 | 192,667 | Feb 26, 2019, 05:33 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 23, 2019 | Option Exercise | $10.51 | 105 | 1,104 | 56,029 | Feb 26, 2019, 05:33 PM |
| Campanelli Paul | President, CEO | Feb 23, 2019 | Option Exercise | $10.51 | 998 | 10,489 | 397,726 | Feb 26, 2019, 05:32 PM |
| Pera Antonio R | President, Par Pharmaceutical | Feb 21, 2019 | Option Exercise | $10.38 | 2,528 | 26,241 | 40,423 | Feb 25, 2019, 04:49 PM |
| Nichol Carrie Ann | VP, Controller & CAO | Feb 21, 2019 | Option Exercise | $10.38 | 760 | 7,889 | 6,592 | Feb 25, 2019, 04:48 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 21, 2019 | Option Exercise | $10.38 | 3,200 | 33,216 | 49,590 | Feb 25, 2019, 04:47 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 21, 2019 | Option Exercise | $10.38 | 4,748 | 49,284 | 191,691 | Feb 25, 2019, 04:47 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Feb 21, 2019 | Option Exercise | $10.38 | 1,621 | 16,826 | 20,698 | Feb 25, 2019, 04:46 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 21, 2019 | Option Exercise | $10.38 | 3,252 | 33,756 | 55,759 | Feb 25, 2019, 04:42 PM |
| Campanelli Paul | President, CEO | Feb 21, 2019 | Option Exercise | $10.38 | 24,184 | 251,030 | 395,769 | Feb 25, 2019, 04:41 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Dec 31, 2018 | Option Exercise | $7.31 | 517 | 3,779 | 42,050 | Jan 02, 2019, 04:24 PM |
| MONTAGUE WILLIAM P | Director | Dec 10, 2018 | Sale | $11.41 | 10,000 | 114,100 | 64,888 | Dec 10, 2018, 04:07 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Dec 01, 2018 | Option Exercise | $12.04 | 2,609 | 31,412 | 17,518 | Dec 03, 2018, 04:29 PM |
| Hutson Nancy J | Director | Nov 15, 2018 | Sale | $12.83 | 10,000 | 128,300 | 49,970 | Nov 16, 2018, 04:03 PM |
| Campanelli Paul | President, CEO | Sep 28, 2018 | Option Exercise | $16.71 | 1,801 | 30,095 | 344,138 | Oct 02, 2018, 04:15 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Sep 28, 2018 | Option Exercise | $16.71 | 1,573 | 26,285 | 177,485 | Oct 02, 2018, 12:00 AM |
| Pera Antonio R | President, Par Pharmaceutical | Oct 01, 2018 | Option Exercise | $17.05 | 124 | 2,114 | 35,201 | Oct 02, 2018, 12:00 AM |
| KIMMEL ROGER H | Director | Aug 14, 2018 | Sale | $15.90 | 12,074 | 191,977 | 145,277 | Aug 15, 2018, 04:22 PM |
| KIMMEL ROGER H | Director | Aug 14, 2018 | Sale | $15.90 | 14,000 | 222,600 | 120,000 | Aug 15, 2018, 04:22 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Aug 10, 2018 | Option Exercise | $15.82 | 13,566 | 214,614 | 41,364 | Aug 14, 2018, 04:12 PM |
| Nichol Carrie Ann | VP, Controller & CAO | Aug 10, 2018 | Option Exercise | $15.82 | 484 | 7,657 | 5,101 | Aug 14, 2018, 04:11 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Aug 10, 2018 | Option Exercise | $15.82 | 17,758 | 280,932 | 175,845 | Aug 14, 2018, 04:10 PM |
| Pera Antonio R | President, Par Pharmaceutical | Aug 10, 2018 | Option Exercise | $15.82 | 5,585 | 88,355 | 34,968 | Aug 14, 2018, 04:09 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Aug 10, 2018 | Option Exercise | $15.82 | 13,636 | 215,722 | 47,955 | Aug 14, 2018, 04:08 PM |
| Barry Patrick A | EVP & Chief Commercial Officer | Aug 10, 2018 | Option Exercise | $15.82 | 3,560 | 56,319 | 12,120 | Aug 14, 2018, 04:08 PM |
| Campanelli Paul | President, CEO | Aug 10, 2018 | Option Exercise | $15.82 | 70,180 | 1,110,248 | 342,097 | Aug 14, 2018, 04:07 PM |
| MONTAGUE WILLIAM P | Director | Jun 08, 2018 | Option Exercise | $7.67 | 18,507 | 141,949 | 74,888 | Jun 12, 2018, 04:19 PM |
| Mansukani Sharad | Director | Jun 08, 2018 | Option Exercise | $7.67 | 15,019 | 115,196 | 43,540 | Jun 12, 2018, 04:16 PM |
| KIMMEL ROGER H | Director | Jun 08, 2018 | Option Exercise | $7.67 | 15,019 | 115,196 | 157,351 | Jun 12, 2018, 04:12 PM |
| HYATT MICHAEL | Director | Jun 08, 2018 | Option Exercise | $7.67 | 15,019 | 115,196 | 279,015 | Jun 12, 2018, 04:10 PM |
| Hutson Nancy J | Director | Jun 08, 2018 | Option Exercise | $7.67 | 15,019 | 115,196 | 59,970 | Jun 12, 2018, 04:09 PM |
| Cooke Shane | Director | Jun 08, 2018 | Option Exercise | $7.67 | 16,271 | 124,799 | 56,244 | Jun 12, 2018, 04:07 PM |
| Nichol Carrie Ann | VP, Controller & CAO | May 26, 2018 | Option Exercise | $6.27 | 237 | 1,486 | 3,883 | May 29, 2018, 12:32 PM |
| Coleman Blaise | EVP, Chief Financial Officer | May 16, 2018 | Option Exercise | $6.29 | 749 | 4,711 | 23,396 | May 17, 2018, 01:38 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Apr 29, 2018 | Option Exercise | $5.90 | 252 | 1,487 | 16,735 | Apr 30, 2018, 01:40 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 23, 2018 | Option Exercise | $6.78 | 433 | 2,936 | 156,103 | Feb 27, 2018, 04:47 PM |
| Rudio Daniel | SVP, Controller | Feb 26, 2018 | Option Exercise | $6.68 | 80 | 534 | 9,669 | Feb 27, 2018, 04:37 PM |
| Rudio Daniel | SVP, Controller | Feb 24, 2018 | Option Exercise | $6.78 | 73 | 495 | 9,549 | Feb 27, 2018, 04:37 PM |
| Rudio Daniel | SVP, Controller | Feb 23, 2018 | Option Exercise | $6.78 | 131 | 888 | 9,438 | Feb 27, 2018, 04:37 PM |
| Pera Antonio R | President, Par Pharmaceutical | Feb 23, 2018 | Option Exercise | $6.78 | 194 | 1,315 | 24,581 | Feb 27, 2018, 04:36 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 23, 2018 | Option Exercise | $6.78 | 384 | 2,604 | 16,084 | Feb 27, 2018, 04:35 PM |
| Campanelli Paul | President, CEO | Feb 23, 2018 | Option Exercise | $6.78 | 942 | 6,387 | 269,777 | Feb 27, 2018, 12:00 AM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 23, 2018 | Option Exercise | $6.78 | 101 | 685 | 21,465 | Feb 27, 2018, 12:00 AM |
| Rudio Daniel | SVP, Controller | Feb 21, 2018 | Option Exercise | $6.72 | 1,301 | 8,743 | 9,242 | Feb 22, 2018, 07:19 PM |
| Pera Antonio R | President, Par Pharmaceutical | Feb 21, 2018 | Option Exercise | $6.72 | 3,117 | 20,946 | 24,203 | Feb 22, 2018, 06:48 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 21, 2018 | Option Exercise | $6.72 | 3,507 | 23,567 | 15,049 | Feb 22, 2018, 06:47 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 21, 2018 | Option Exercise | $6.72 | 6,816 | 45,804 | 155,246 | Feb 22, 2018, 06:45 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 21, 2018 | Option Exercise | $6.72 | 3,595 | 24,158 | 21,191 | Feb 22, 2018, 06:44 PM |
| Campanelli Paul | President, CEO | Feb 21, 2018 | Option Exercise | $6.72 | 24,184 | 162,516 | 267,763 | Feb 22, 2018, 06:43 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Dec 31, 2017 | Option Exercise | $7.85 | 372 | 2,920 | 7,815 | Jan 02, 2018, 04:36 PM |
| KIMMEL ROGER H | Director | Nov 15, 2017 | Sale | $6.90 | 4,000 | 27,600 | 136,140 | Nov 17, 2017, 04:03 PM |
| KIMMEL ROGER H | Director | Nov 15, 2017 | Sale | $6.90 | 5,134 | 35,425 | 138,939 | Nov 17, 2017, 04:03 PM |
| Mansukani Sharad | Director | Nov 08, 2017 | Option Exercise | $6.09 | 3,206 | 19,525 | 27,268 | Nov 13, 2017, 04:07 PM |
| Pera Antonio R | President, Par Pharmaceutical | Oct 01, 2017 | Option Exercise | $8.48 | 135 | 1,145 | 19,570 | Oct 02, 2017, 05:00 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Sep 28, 2017 | Option Exercise | $8.38 | 1,187 | 9,947 | 143,108 | Oct 02, 2017, 04:53 PM |
| Campanelli Paul | President, CEO | Sep 28, 2017 | Option Exercise | $8.38 | 1,330 | 11,145 | 216,132 | Oct 02, 2017, 04:50 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Aug 15, 2017 | Buy | $8.02 | 3,000 | 24,060 | 6,984 | Aug 15, 2017, 02:55 PM |
| Campanelli Paul | President, CEO | Aug 14, 2017 | Buy | $7.71 | 6,500 | 50,115 | 213,620 | Aug 15, 2017, 02:31 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Aug 15, 2017 | Buy | $7.89 | 6,500 | 51,285 | 13,729 | Aug 15, 2017, 02:15 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Aug 10, 2017 | Buy | $7.70 | 20,000 | 154,000 | 140,582 | Aug 11, 2017, 09:04 AM |
| MONTAGUE WILLIAM P | Director | Jun 09, 2017 | Option Exercise | $11.49 | 11,488 | 131,997 | 51,674 | Jun 12, 2017, 09:42 PM |
| INGRAM DOUGLAS S | Director | Jun 09, 2017 | Option Exercise | $11.49 | 11,488 | 131,997 | 17,336 | Jun 12, 2017, 09:40 PM |
| HYATT MICHAEL | Director | Jun 09, 2017 | Option Exercise | $11.49 | 11,488 | 131,997 | 262,743 | Jun 12, 2017, 09:39 PM |
| Hutson Nancy J | Director | Jun 09, 2017 | Option Exercise | $11.49 | 11,488 | 131,997 | 43,698 | Jun 12, 2017, 09:38 PM |
| Coleman Blaise | EVP, Chief Financial Officer | May 16, 2017 | Option Exercise | $13.33 | 830 | 11,064 | 7,229 | May 17, 2017, 05:42 PM |
| Rudio Daniel | SVP, Controller | May 16, 2017 | Option Exercise | $13.33 | 892 | 11,890 | 7,298 | May 17, 2017, 05:38 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Apr 29, 2017 | Option Exercise | $11.42 | 279 | 3,186 | 3,984 | May 01, 2017, 02:18 PM |
| Campanelli Paul | President, CEO | Mar 16, 2017 | Buy | $10.72 | 2,300 | 24,656 | 207,120 | Mar 16, 2017, 05:54 PM |
| Hutson Nancy J | Director | Mar 09, 2017 | Sale | $10.82 | 5,325 | 57,616 | 31,252 | Mar 10, 2017, 10:24 AM |
| Rudio Daniel | SVP, Controller | Feb 26, 2017 | Option Exercise | $13.27 | 86 | 1,141 | 5,442 | Feb 28, 2017, 06:32 PM |
| Rudio Daniel | SVP, Controller | Feb 27, 2017 | Option Exercise | $13.27 | 293 | 3,888 | 5,830 | Feb 28, 2017, 06:32 PM |
| Rudio Daniel | SVP, Controller | Feb 24, 2017 | Option Exercise | $13.27 | 79 | 1,048 | 5,328 | Feb 27, 2017, 02:54 PM |
| Rudio Daniel | SVP, Controller | Feb 23, 2017 | Option Exercise | $13.22 | 141 | 1,864 | 5,223 | Feb 27, 2017, 02:54 PM |
| Pera Antonio R | President, Par Pharmaceutical | Feb 23, 2017 | Option Exercise | $13.22 | 247 | 3,265 | 19,348 | Feb 27, 2017, 02:53 PM |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | Feb 23, 2017 | Option Exercise | $13.22 | 514 | 6,795 | 3,360 | Feb 27, 2017, 02:51 PM |
| Coughlin Terrance J | EVP, Chief Operating Officer | Feb 23, 2017 | Option Exercise | $13.22 | 545 | 7,205 | 120,582 | Feb 27, 2017, 02:48 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Feb 23, 2017 | Option Exercise | $13.22 | 113 | 1,494 | 5,378 | Feb 27, 2017, 02:47 PM |
| Campanelli Paul | President, CEO | Feb 23, 2017 | Option Exercise | $13.22 | 1,066 | 14,093 | 204,820 | Feb 27, 2017, 02:44 PM |
| Coleman Blaise | EVP, Chief Financial Officer | Jan 28, 2017 | Option Exercise | $11.96 | 1,117 | 13,359 | 5,115 | Jan 31, 2017, 03:49 PM |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | Dec 31, 2016 | Option Exercise | $16.16 | 372 | 6,012 | 2,455 | Jan 03, 2017, 04:58 PM |
| KIMMEL ROGER H | Director | Nov 15, 2016 | Sale | $17.38 | 7,000 | 121,632 | 188,050 | Nov 16, 2016, 02:00 PM |
| KIMMEL ROGER H | Director | Nov 15, 2016 | Sale | $17.38 | 7,000 | 121,632 | 68,412 | Nov 16, 2016, 02:00 PM |
| Campanelli Paul | President & CEO | Sep 28, 2016 | Option Exercise | $22.26 | 1,981 | 44,097 | 202,930 | Sep 28, 2016, 06:25 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Sep 24, 2016 | Option Exercise | $22.44 | 1,618 | 36,308 | 22,412 | Sep 27, 2016, 04:03 PM |
| INGRAM DOUGLAS S | Director | May 05, 2016 | Option Exercise | $26.59 | 9,403 | 250,026 | 9,403 | May 18, 2016, 04:28 PM |
| INGRAM DOUGLAS S | Director | May 05, 2016 | Sale | $26.59 | 4,513 | 120,001 | 4,890 | May 18, 2016, 04:28 PM |
| HIGGINS ARTHUR J | Director | May 11, 2016 | Buy | $13.80 | 5,000 | 69,000 | 50,623 | May 12, 2016, 01:08 PM |
| KIMMEL ROGER H | Director | May 10, 2016 | Buy | $15.48 | 5,000 | 77,400 | 195,000 | May 11, 2016, 02:26 PM |
| KIMMEL ROGER H | Director | May 10, 2016 | Buy | $15.66 | 2,000 | 31,320 | 75,362 | May 11, 2016, 02:26 PM |
| HIGGINS ARTHUR J | Director | May 10, 2016 | Buy | $15.42 | 11,000 | 169,620 | 45,623 | May 11, 2016, 02:22 PM |
| Campanelli Paul | Group President, Generics | May 10, 2016 | Buy | $15.53 | 13,000 | 201,890 | 201,069 | May 11, 2016, 02:20 PM |
| INGRAM DOUGLAS S | Director | May 05, 2016 | Option Exercise | $26.59 | 9,403 | 250,026 | 9,403 | May 09, 2016, 04:41 PM |
| Varghese Hemanth Jacob | Pres. International Pharma | Apr 29, 2016 | Option Exercise | $27.56 | 449 | 12,374 | 4,350 | May 02, 2016, 04:46 PM |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | Apr 29, 2016 | Option Exercise | $27.56 | 279 | 7,689 | 1,624 | May 02, 2016, 04:41 PM |
| MONTAGUE WILLIAM P | Director | Mar 01, 2016 | Sale | $42.19 | 3,413 | 143,994 | 39,228 | Apr 21, 2016, 05:07 PM |
| DE SILVA RAJIV | President & CEO | Mar 18, 2016 | Option Exercise | $30.43 | 6,244 | 190,005 | 258,158 | Mar 22, 2016, 04:10 PM |
| DE SILVA RAJIV | President & CEO | Mar 21, 2016 | Option Exercise | $29.78 | 28,099 | 836,788 | 291,695 | Mar 22, 2016, 04:10 PM |
| Spengler William | Director | Mar 17, 2016 | Buy | $29.20 | 1,000 | 29,200 | 48,835 | Mar 17, 2016, 07:03 PM |
| Spengler William | Director | Mar 16, 2016 | Buy | $35.24 | 1,000 | 35,240 | 47,835 | Mar 16, 2016, 01:36 PM |
| Hall Susan | EVP, CSO, Global Head of R&D | Mar 11, 2016 | Option Exercise | $41.67 | 626 | 26,085 | 4,826 | Mar 14, 2016, 05:53 PM |
| KIMMEL ROGER H | Director | Mar 11, 2016 | Option Exercise | $41.67 | 6,764 | 281,856 | 72,237 | Mar 14, 2016, 03:07 PM |
| KIMMEL ROGER H | Director | Mar 14, 2016 | Buy | $41.94 | 1,125 | 47,182 | 73,362 | Mar 14, 2016, 03:07 PM |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | Mar 07, 2016 | Buy | $44.48 | 500 | 22,240 | 1,000 | Mar 07, 2016, 03:58 PM |
| DE SILVA RAJIV | President & CEO | Mar 07, 2016 | Buy | $44.50 | 2,250 | 100,125 | 250,705 | Mar 07, 2016, 03:57 PM |
| Lortie Brian | President Branded Pharma | Mar 02, 2016 | Option Exercise | $43.06 | 2,451 | 105,540 | 24,504 | Mar 04, 2016, 04:45 PM |
| DE SILVA RAJIV | President & CEO | Mar 02, 2016 | Option Exercise | $43.06 | 56,198 | 2,419,886 | 248,455 | Mar 04, 2016, 04:43 PM |
| Spengler William | Director | Mar 01, 2016 | Sale | $42.19 | 3,413 | 143,994 | 46,835 | Mar 03, 2016, 08:58 PM |
| Smith Jill D. | Director | Mar 01, 2016 | Sale | $42.19 | 3,413 | 143,994 | 19,785 | Mar 03, 2016, 08:57 PM |
| HYATT MICHAEL | Director | Mar 01, 2016 | Sale | $42.19 | 3,413 | 143,994 | 250,297 | Mar 03, 2016, 08:55 PM |
| Hutson Nancy J | Director | Mar 01, 2016 | Sale | $42.19 | 3,413 | 143,994 | 36,577 | Mar 03, 2016, 08:53 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 26, 2016 | Option Exercise | $53.80 | 399 | 21,466 | 18,292 | Mar 01, 2016, 06:11 PM |
| Rudio Daniel | Vice President, Controller | Feb 27, 2016 | Option Exercise | $53.80 | 287 | 15,441 | 4,408 | Mar 01, 2016, 06:09 PM |
| Rudio Daniel | Vice President, Controller | Feb 26, 2016 | Option Exercise | $53.80 | 86 | 4,627 | 4,013 | Mar 01, 2016, 06:09 PM |
| Lortie Brian | President Branded Pharma | Feb 27, 2016 | Option Exercise | $53.80 | 200 | 10,760 | 19,169 | Mar 01, 2016, 06:07 PM |
| Lortie Brian | President Branded Pharma | Feb 26, 2016 | Option Exercise | $53.80 | 130 | 6,994 | 18,720 | Mar 01, 2016, 06:07 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 24, 2016 | Option Exercise | $49.85 | 693 | 34,546 | 17,423 | Feb 25, 2016, 08:20 PM |
| Rudio Daniel | Vice President, Controller | Feb 24, 2016 | Option Exercise | $49.85 | 79 | 3,938 | 3,898 | Feb 25, 2016, 08:20 PM |
| Lortie Brian | President Branded Pharma | Feb 24, 2016 | Option Exercise | $49.85 | 240 | 11,964 | 18,425 | Feb 25, 2016, 08:19 PM |
| Hall Susan | EVP, CSO, Global Head of R&D | Feb 24, 2016 | Option Exercise | $49.85 | 239 | 11,914 | 3,160 | Feb 25, 2016, 08:17 PM |
| Lortie Brian | President Branded Pharma | Feb 22, 2016 | Option Exercise | $50.70 | 305 | 15,464 | 18,010 | Feb 24, 2016, 05:59 PM |
| Rudio Daniel | Vice President, Controller | Feb 22, 2016 | Option Exercise | $50.70 | 192 | 9,734 | 3,793 | Feb 24, 2016, 05:53 PM |
| KIMMEL ROGER H | Director | Nov 16, 2015 | Buy | $57.00 | 841 | 47,937 | 108,362 | Nov 17, 2015, 10:40 AM |
| KIMMEL ROGER H | Director | Nov 11, 2015 | Option Exercise | $16.80 | 10,384 | 174,451 | 107,521 | Nov 12, 2015, 09:15 PM |
| Cooke Shane | Director | Nov 12, 2015 | Buy | $57.13 | 4,000 | 228,520 | 10,179 | Nov 12, 2015, 05:36 PM |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | Nov 11, 2015 | Buy | $56.19 | 500 | 28,095 | 500 | Nov 12, 2015, 07:38 AM |
| Lortie Brian | President Branded Pharma | Nov 11, 2015 | Buy | $56.47 | 700 | 39,529 | 17,484 | Nov 12, 2015, 07:37 AM |
| HYATT MICHAEL | Director | Nov 11, 2015 | Option Exercise | $31.43 | 10,000 | 314,300 | 259,599 | Nov 12, 2015, 07:37 AM |
| HYATT MICHAEL | Director | Nov 11, 2015 | Sale | $55.48 | 8,000 | 443,840 | 251,599 | Nov 12, 2015, 07:37 AM |
| Hall Susan | EVP, CSO, Global Head of R&D | Nov 11, 2015 | Buy | $55.35 | 1,000 | 55,350 | 2,666 | Nov 12, 2015, 07:36 AM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Nov 11, 2015 | Buy | $56.37 | 4,450 | 250,856 | 15,886 | Nov 12, 2015, 07:35 AM |
| Campanelli Paul | President, Par Pharmaceutical | Nov 11, 2015 | Buy | $55.69 | 2,100 | 116,954 | 188,069 | Nov 12, 2015, 07:35 AM |
| DE SILVA RAJIV | President & CEO | Nov 11, 2015 | Buy | $55.52 | 9,006 | 500,013 | 181,380 | Nov 12, 2015, 07:33 AM |
| KIMMEL ROGER H | Director | Nov 05, 2015 | Option Exercise | $53.91 | 10,000 | 539,100 | 237,137 | Nov 06, 2015, 05:37 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Sep 24, 2015 | Option Exercise | $72.77 | 2,368 | 172,319 | 11,335 | Sep 28, 2015, 05:23 PM |
| HIGGINS ARTHUR J | Director | Jun 16, 2015 | Buy | $81.10 | 2,500 | 202,750 | 22,771 | Jun 18, 2015, 04:44 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Apr 08, 2015 | Option Exercise | $29.56 | 105,059 | 3,105,904 | 148,159 | Apr 09, 2015, 05:16 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Apr 07, 2015 | Option Exercise | $20.61 | 503 | 10,367 | 43,603 | Apr 09, 2015, 05:16 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Apr 07, 2015 | Sale | $91.90 | 503 | 46,226 | 43,100 | Apr 09, 2015, 05:16 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Apr 08, 2015 | Sale | $91.90 | 105,059 | 9,654,922 | 43,100 | Apr 09, 2015, 05:16 PM |
| Hall Susan | EVP, CSO, Global Head of R&D | Mar 11, 2015 | Option Exercise | $89.44 | 626 | 55,989 | 1,666 | Mar 13, 2015, 06:16 PM |
| Farhat Camille | President, AMS, Inc. | Mar 10, 2015 | Sale | $89.39 | 8,650 | 773,223 | 0 | Mar 12, 2015, 05:25 PM |
| Farhat Camille | President, AMS, Inc. | Mar 09, 2015 | Option Exercise | $32.09 | 40,438 | 1,297,806 | 49,088 | Mar 11, 2015, 04:39 PM |
| Farhat Camille | President, AMS, Inc. | Mar 09, 2015 | Sale | $87.02 | 40,438 | 3,518,915 | 8,650 | Mar 11, 2015, 04:39 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Mar 05, 2015 | Option Exercise | $19.93 | 42,033 | 837,718 | 85,133 | Mar 09, 2015, 04:51 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Mar 05, 2015 | Sale | $87.78 | 42,033 | 3,689,657 | 43,100 | Mar 09, 2015, 04:51 PM |
| Lortie Brian | President Branded Pharma | Mar 04, 2015 | Sale | $85.35 | 5,800 | 495,030 | 16,784 | Mar 06, 2015, 04:56 PM |
| Rudio Daniel | Vice President, Controller | Feb 27, 2015 | Option Exercise | $85.34 | 251 | 21,420 | 3,285 | Mar 02, 2015, 05:27 PM |
| Rudio Daniel | Vice President, Controller | Feb 26, 2015 | Option Exercise | $85.19 | 81 | 6,900 | 2,854 | Mar 02, 2015, 05:27 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Feb 27, 2015 | Option Exercise | $85.34 | 1,009 | 86,108 | 43,100 | Mar 02, 2015, 05:26 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Feb 26, 2015 | Option Exercise | $85.19 | 609 | 51,881 | 42,130 | Mar 02, 2015, 05:26 PM |
| Farhat Camille | President, AMS, Inc. | Feb 27, 2015 | Option Exercise | $85.34 | 352 | 30,040 | 8,650 | Mar 02, 2015, 05:24 PM |
| Farhat Camille | President, AMS, Inc. | Feb 26, 2015 | Option Exercise | $85.19 | 652 | 55,544 | 8,270 | Mar 02, 2015, 05:24 PM |
| DeGolyer Donald W | Chief Operating Officer,Pharma | Feb 26, 2015 | Option Exercise | $85.19 | 477 | 40,636 | 6,547 | Mar 02, 2015, 05:21 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Feb 26, 2015 | Option Exercise | $85.19 | 402 | 34,246 | 8,382 | Mar 02, 2015, 05:20 PM |
| Rudio Daniel | Vice President, Controller | Feb 23, 2015 | Option Exercise | $85.82 | 138 | 11,843 | 2,734 | Feb 24, 2015, 04:17 PM |
| Rudio Daniel | Vice President, Controller | Feb 22, 2015 | Option Exercise | $85.30 | 192 | 16,378 | 2,550 | Feb 24, 2015, 04:17 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Feb 22, 2015 | Option Exercise | $85.30 | 1,673 | 142,707 | 36,132 | Feb 24, 2015, 04:16 PM |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | Feb 23, 2015 | Option Exercise | $85.82 | 1,495 | 128,301 | 37,570 | Feb 24, 2015, 04:16 PM |
| DE SILVA RAJIV | President & CEO | Dec 31, 2014 | Option Exercise | $72.90 | 6,244 | 455,188 | 172,374 | Jan 05, 2015, 05:24 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Nov 14, 2014 | Buy | $66.94 | 3,700 | 247,678 | 7,222 | Nov 18, 2014, 04:55 PM |
| KIMMEL ROGER H | Director | Oct 14, 2014 | Option Exercise | $29.84 | 4,567 | 136,279 | 220,394 | Oct 16, 2014, 05:42 PM |
| Upadhyay Suketu | EVP, Chief Financial Officer | Sep 24, 2014 | Option Exercise | $66.54 | 1,618 | 107,662 | 3,522 | Sep 25, 2014, 06:20 PM |
| Farhat Camille | President, AMS, Inc. | Sep 05, 2014 | Option Exercise | $63.36 | 1,789 | 113,351 | 7,568 | Sep 09, 2014, 04:49 PM |
| HYATT MICHAEL | Director | Aug 19, 2014 | Option Exercise | $22.06 | 10,000 | 220,600 | 244,228 | Aug 21, 2014, 04:07 PM |
| KIMMEL ROGER H | Director | Aug 11, 2014 | Option Exercise | $22.06 | 10,000 | 220,600 | 211,126 | Aug 13, 2014, 04:33 PM |
| HIGGINS ARTHUR J | Director | Aug 05, 2014 | Buy | $65.65 | 3,500 | 229,775 | 8,827 | Aug 07, 2014, 05:15 PM |
| DeGolyer Donald W | Chief Operating Officer,Pharma | Aug 02, 2014 | Option Exercise | $68.10 | 4,459 | 303,658 | 5,743 | Aug 05, 2014, 04:11 PM |
| DELUCCA JOHN | Director | Jun 09, 2014 | Option Exercise | $24.63 | 6,764 | 166,597 | 34,875 | Jun 10, 2014, 04:13 PM |
| DELUCCA JOHN | Director | Jun 09, 2014 | Sale | $68.83 | 6,764 | 465,566 | 28,111 | Jun 10, 2014, 04:13 PM |
| MANOGUE CAROLINE B | Exec. V.P., CLO & Secy | May 29, 2014 | Option Exercise | $25.13 | 175,033 | 4,398,608 | 209,596 | Jun 02, 2014, 04:11 PM |
| MANOGUE CAROLINE B | Exec. V.P., CLO & Secy | May 29, 2014 | Sale | $72.02 | 175,033 | 12,605,876 | 34,563 | Jun 02, 2014, 04:11 PM |
| DELUCCA JOHN | Director | May 01, 2014 | Option Exercise | $23.82 | 8,094 | 192,799 | 29,690 | May 02, 2014, 06:05 PM |
| DELUCCA JOHN | Director | May 01, 2014 | Sale | $66.31 | 8,094 | 536,713 | 21,596 | May 02, 2014, 06:05 PM |
| DELUCCA JOHN | Director | Apr 01, 2014 | Option Exercise | $16.80 | 10,384 | 174,451 | 31,980 | Apr 02, 2014, 06:01 PM |
| DELUCCA JOHN | Director | Apr 01, 2014 | Sale | $68.46 | 10,384 | 710,889 | 21,596 | Apr 02, 2014, 06:01 PM |
| Hutson Nancy J | Director | Mar 10, 2014 | Option Exercise | $17.27 | 5,000 | 86,350 | 25,483 | Mar 11, 2014, 08:19 PM |
| Hutson Nancy J | Director | Mar 10, 2014 | Sale | $72.12 | 5,000 | 360,600 | 20,483 | Mar 11, 2014, 08:19 PM |
| HIGGINS ARTHUR J | Director | Mar 10, 2014 | Buy | $73.00 | 5,000 | 365,000 | 5,000 | Mar 11, 2014, 08:18 PM |
| Gergel Ivan P. | EVP, R&D and CSO | Mar 10, 2014 | Option Exercise | $31.13 | 75,637 | 2,354,595 | 58,811 | Mar 11, 2014, 08:18 PM |
| Gergel Ivan P. | EVP, R&D and CSO | Mar 10, 2014 | Sale | $72.47 | 75,637 | 5,481,413 | 27,649 | Mar 11, 2014, 08:18 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 03/29/2022 | 10,435 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 03/30/2022 | 12,537 |
| Raciti Frank B. | VP, Controller and CAO | 03/29/2022 | 2,432 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 03/30/2022 | 25,651 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 03/29/2022 | 21,349 |
| Bradley Mark T. | EVP, Chief Financial Officer | 03/30/2022 | 7,704 |
| Bradley Mark T. | EVP, Chief Financial Officer | 03/29/2022 | 6,411 |
| Coleman Blaise | President, CEO | 03/30/2022 | 25,545 |
| Coleman Blaise | President, CEO | 03/29/2022 | 21,261 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 03/05/2022 | 18,396 |
| Raciti Frank B. | VP, Controller and CAO | 03/05/2022 | 923 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 03/05/2022 | 21,364 |
| Smith Mary Christine | Director | 06/11/2021 | 156,957 |
| Barberio Mark G | Director | 06/11/2021 | 143,999 |
| MONTAGUE WILLIAM P | Director | 06/11/2021 | 143,999 |
| Apostol George | EVP, Global R&D | 06/01/2021 | 47,362 |
| Boyle Jack D. | SVP, Controller | 04/06/2021 | 27,468 |
| Boyle Jack D. | SVP, Controller | 04/02/2021 | 22,375 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 04/06/2021 | 219,147 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 04/02/2021 | 178,509 |
| Campanelli Paul | Director | 04/06/2021 | 1,388,390 |
| Campanelli Paul | Director | 04/02/2021 | 1,078,968 |
| Bradley Mark T. | EVP, Chief Financial Officer | 03/29/2021 | 18,604 |
| Campanelli Paul | Director | 03/29/2021 | 533,301 |
| Boyle Jack D. | SVP, Controller | 03/29/2021 | 21,778 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 03/29/2021 | 45,552 |
| Maletta Matthew Joseph | EVP, CLO & Company Secretary | 03/29/2021 | 92,976 |
| Coleman Blaise | President, CEO | 03/29/2021 | 94,483 |
| MONTAGUE WILLIAM P | Director | 03/15/2021 | 78,406 |
| Cooke Shane | Director | 03/15/2021 | 149,558 |
| Smith Mary Christine | Director | 07/29/2020 | 17,901 |
| Ciarico Domenico | EVP & Chief Commercial Officer | 09/03/2020 | 55,834 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 08/10/2020 | 56,137 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 08/10/2020 | 12,554 |
| Boyle Jack D. | SVP, Controller | 08/10/2020 | 2,326 |
| Coleman Blaise | President, CEO | 08/10/2020 | 56,137 |
| Campanelli Paul | Director | 08/10/2020 | 397,083 |
| Bradley Mark T. | EVP, Chief Financial Officer | 08/10/2020 | 4,665 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 08/10/2020 | 18,479 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 08/10/2020 | 62,434 |
| Ciarico Domenico | EVP & Chief Commercial Officer | 08/01/2020 | 10,092 |
| Smith Mary Christine | Director | 07/29/2020 | 35,802 |
| Smith Mary Christine | Director | 07/29/2020 | 35,802 |
| Cooke Shane | Director | 06/12/2020 | 45,499 |
| Barberio Mark G | Director | 06/12/2020 | 42,000 |
| MONTAGUE WILLIAM P | Director | 06/12/2020 | 42,000 |
| KIMMEL ROGER H | Director | 06/12/2020 | 42,000 |
| HYATT MICHAEL | Director | 06/12/2020 | 42,000 |
| Hutson Nancy J | Director | 06/12/2020 | 42,000 |
| Bradley Mark T. | EVP, Chief Financial Officer | 04/02/2020 | 19,447 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 04/02/2020 | 77,205 |
| Coleman Blaise | President, CEO | 04/02/2020 | 79,177 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 04/02/2020 | 28,827 |
| Barry Patrick A | EVP & Pres,Global Comm Ops | 04/02/2020 | 21,918 |
| Boyle Jack D. | SVP, Controller | 04/02/2020 | 9,594 |
| Campanelli Paul | Director | 04/02/2020 | 462,624 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 04/02/2020 | 110,530 |
| Coleman Blaise | President, CEO | 03/29/2020 | 48,312 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 03/29/2020 | 45,148 |
| Barry Patrick A | EVP & Chief Commercial Officer | 03/29/2020 | 14,474 |
| Campanelli Paul | Director | 03/29/2020 | 256,700 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 03/29/2020 | 14,623 |
| Bradley Mark T. | EVP, Chief Financial Officer | 03/29/2020 | 9,289 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 03/29/2020 | 62,607 |
| Ciarico Domenico | EVP & Chief Commercial Officer | 03/29/2020 | 4,879 |
| Boyle Jack D. | SVP, Controller | 03/29/2020 | 10,483 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/25/2020 | 53,104 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/23/2020 | 650 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/21/2020 | 19,319 |
| Campanelli Paul | President, CEO | 02/25/2020 | 575,521 |
| Campanelli Paul | President, CEO | 02/23/2020 | 6,178 |
| Campanelli Paul | President, CEO | 02/21/2020 | 149,699 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/23/2020 | 4,902 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/21/2020 | 58,446 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/25/2020 | 161,268 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 02/25/2020 | 27,734 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 02/23/2020 | 1,002 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 02/21/2020 | 10,088 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/25/2020 | 51,581 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/23/2020 | 2,476 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/21/2020 | 18,762 |
| Boyle Jack D. | SVP, Controller | 02/25/2020 | 6,834 |
| Boyle Jack D. | SVP, Controller | 02/23/2020 | 514 |
| Boyle Jack D. | SVP, Controller | 02/21/2020 | 2,519 |
| Barry Patrick A | EVP & Chief Commercial Officer | 02/25/2020 | 23,262 |
| Barry Patrick A | EVP & Chief Commercial Officer | 02/21/2020 | 8,462 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 12/31/2019 | 2,745 |
| Barry Patrick A | EVP & Chief Commercial Officer | 12/01/2019 | 12,964 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 10/01/2019 | 367 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 09/28/2019 | 1,853 |
| Campanelli Paul | President, CEO | 09/28/2019 | 5,847 |
| KIMMEL ROGER H | Director | 09/16/2019 | 122,700 |
| KIMMEL ROGER H | Director | 09/16/2019 | 102,250 |
| Nichol Carrie Ann | SVP, Controller & CAO | 08/10/2019 | 1,205 |
| Garella Rahul | EVP, Intl Pharmaceuticals | 08/10/2019 | 9,201 |
| Barry Patrick A | EVP & Chief Commercial Officer | 08/10/2019 | 8,864 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 08/10/2019 | 41,112 |
| Coleman Blaise | EVP, Chief Financial Officer | 08/10/2019 | 41,112 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 08/10/2019 | 45,724 |
| Campanelli Paul | President, CEO | 08/10/2019 | 290,807 |
| KIMMEL ROGER H | Director | 06/17/2019 | 39,300 |
| KIMMEL ROGER H | Director | 06/17/2019 | 98,057 |
| HYATT MICHAEL | Director | 06/12/2019 | 115,197 |
| MONTAGUE WILLIAM P | Director | 06/12/2019 | 115,197 |
| Mansukani Sharad | Director | 06/12/2019 | 115,197 |
| KIMMEL ROGER H | Director | 06/12/2019 | 115,197 |
| Hutson Nancy J | Director | 06/12/2019 | 115,197 |
| Cooke Shane | Director | 06/12/2019 | 124,800 |
| Nichol Carrie Ann | SVP, Controller & CAO | 05/26/2019 | 1,427 |
| Coleman Blaise | EVP, Chief Financial Officer | 05/16/2019 | 7,747 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 04/29/2019 | 2,984 |
| Pera Antonio R | President, Par Pharmaceutical | 04/02/2019 | 94,519 |
| Nichol Carrie Ann | SVP, Controller & CAO | 04/02/2019 | 18,104 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 04/02/2019 | 171,250 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 04/02/2019 | 302,883 |
| Barry Patrick A | EVP & Chief Commercial Officer | 04/02/2019 | 85,115 |
| Coleman Blaise | EVP, Chief Financial Officer | 04/02/2019 | 191,759 |
| Campanelli Paul | President, CEO | 04/02/2019 | 1,185,840 |
| Pera Antonio R | President, Par Pharmaceutical | 02/23/2019 | 1,955 |
| Nichol Carrie Ann | VP, Controller & CAO | 02/23/2019 | 788 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/23/2019 | 4,204 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/23/2019 | 3,300 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/23/2019 | 1,104 |
| Campanelli Paul | President, CEO | 02/23/2019 | 10,489 |
| Pera Antonio R | President, Par Pharmaceutical | 02/21/2019 | 26,241 |
| Nichol Carrie Ann | VP, Controller & CAO | 02/21/2019 | 7,889 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/21/2019 | 33,216 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/21/2019 | 49,284 |
| Barry Patrick A | EVP & Chief Commercial Officer | 02/21/2019 | 16,826 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/21/2019 | 33,756 |
| Campanelli Paul | President, CEO | 02/21/2019 | 251,030 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 12/31/2018 | 3,779 |
| MONTAGUE WILLIAM P | Director | 12/10/2018 | 114,100 |
| Barry Patrick A | EVP & Chief Commercial Officer | 12/01/2018 | 31,412 |
| Hutson Nancy J | Director | 11/15/2018 | 128,300 |
| Campanelli Paul | President, CEO | 09/28/2018 | 30,095 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 09/28/2018 | 26,285 |
| Pera Antonio R | President, Par Pharmaceutical | 10/01/2018 | 2,114 |
| KIMMEL ROGER H | Director | 08/14/2018 | 191,977 |
| KIMMEL ROGER H | Director | 08/14/2018 | 222,600 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 08/10/2018 | 214,614 |
| Nichol Carrie Ann | VP, Controller & CAO | 08/10/2018 | 7,657 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 08/10/2018 | 280,932 |
| Pera Antonio R | President, Par Pharmaceutical | 08/10/2018 | 88,355 |
| Coleman Blaise | EVP, Chief Financial Officer | 08/10/2018 | 215,722 |
| Barry Patrick A | EVP & Chief Commercial Officer | 08/10/2018 | 56,319 |
| Campanelli Paul | President, CEO | 08/10/2018 | 1,110,248 |
| MONTAGUE WILLIAM P | Director | 06/08/2018 | 141,949 |
| Mansukani Sharad | Director | 06/08/2018 | 115,196 |
| KIMMEL ROGER H | Director | 06/08/2018 | 115,196 |
| HYATT MICHAEL | Director | 06/08/2018 | 115,196 |
| Hutson Nancy J | Director | 06/08/2018 | 115,196 |
| Cooke Shane | Director | 06/08/2018 | 124,799 |
| Nichol Carrie Ann | VP, Controller & CAO | 05/26/2018 | 1,486 |
| Coleman Blaise | EVP, Chief Financial Officer | 05/16/2018 | 4,711 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 04/29/2018 | 1,487 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/23/2018 | 2,936 |
| Rudio Daniel | SVP, Controller | 02/26/2018 | 534 |
| Rudio Daniel | SVP, Controller | 02/24/2018 | 495 |
| Rudio Daniel | SVP, Controller | 02/23/2018 | 888 |
| Pera Antonio R | President, Par Pharmaceutical | 02/23/2018 | 1,315 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/23/2018 | 2,604 |
| Campanelli Paul | President, CEO | 02/23/2018 | 6,387 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/23/2018 | 685 |
| Rudio Daniel | SVP, Controller | 02/21/2018 | 8,743 |
| Pera Antonio R | President, Par Pharmaceutical | 02/21/2018 | 20,946 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/21/2018 | 23,567 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/21/2018 | 45,804 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/21/2018 | 24,158 |
| Campanelli Paul | President, CEO | 02/21/2018 | 162,516 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 12/31/2017 | 2,920 |
| KIMMEL ROGER H | Director | 11/15/2017 | 27,600 |
| KIMMEL ROGER H | Director | 11/15/2017 | 35,425 |
| Mansukani Sharad | Director | 11/08/2017 | 19,525 |
| Pera Antonio R | President, Par Pharmaceutical | 10/01/2017 | 1,145 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 09/28/2017 | 9,947 |
| Campanelli Paul | President, CEO | 09/28/2017 | 11,145 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 08/15/2017 | 24,060 |
| Campanelli Paul | President, CEO | 08/14/2017 | 50,115 |
| Coleman Blaise | EVP, Chief Financial Officer | 08/15/2017 | 51,285 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 08/10/2017 | 154,000 |
| MONTAGUE WILLIAM P | Director | 06/09/2017 | 131,997 |
| INGRAM DOUGLAS S | Director | 06/09/2017 | 131,997 |
| HYATT MICHAEL | Director | 06/09/2017 | 131,997 |
| Hutson Nancy J | Director | 06/09/2017 | 131,997 |
| Coleman Blaise | EVP, Chief Financial Officer | 05/16/2017 | 11,064 |
| Rudio Daniel | SVP, Controller | 05/16/2017 | 11,890 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 04/29/2017 | 3,186 |
| Campanelli Paul | President, CEO | 03/16/2017 | 24,656 |
| Hutson Nancy J | Director | 03/09/2017 | 57,616 |
| Rudio Daniel | SVP, Controller | 02/26/2017 | 1,141 |
| Rudio Daniel | SVP, Controller | 02/27/2017 | 3,888 |
| Rudio Daniel | SVP, Controller | 02/24/2017 | 1,048 |
| Rudio Daniel | SVP, Controller | 02/23/2017 | 1,864 |
| Pera Antonio R | President, Par Pharmaceutical | 02/23/2017 | 3,265 |
| Maletta Matthew Joseph | EVP, Chief Legal Officer | 02/23/2017 | 6,795 |
| Coughlin Terrance J | EVP, Chief Operating Officer | 02/23/2017 | 7,205 |
| Coleman Blaise | EVP, Chief Financial Officer | 02/23/2017 | 1,494 |
| Campanelli Paul | President, CEO | 02/23/2017 | 14,093 |
| Coleman Blaise | EVP, Chief Financial Officer | 01/28/2017 | 13,359 |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | 12/31/2016 | 6,012 |
| KIMMEL ROGER H | Director | 11/15/2016 | 121,632 |
| KIMMEL ROGER H | Director | 11/15/2016 | 121,632 |
| Campanelli Paul | President & CEO | 09/28/2016 | 44,097 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 09/24/2016 | 36,308 |
| INGRAM DOUGLAS S | Director | 05/05/2016 | 250,026 |
| INGRAM DOUGLAS S | Director | 05/05/2016 | 120,001 |
| HIGGINS ARTHUR J | Director | 05/11/2016 | 69,000 |
| KIMMEL ROGER H | Director | 05/10/2016 | 77,400 |
| KIMMEL ROGER H | Director | 05/10/2016 | 31,320 |
| HIGGINS ARTHUR J | Director | 05/10/2016 | 169,620 |
| Campanelli Paul | Group President, Generics | 05/10/2016 | 201,890 |
| INGRAM DOUGLAS S | Director | 05/05/2016 | 250,026 |
| Varghese Hemanth Jacob | Pres. International Pharma | 04/29/2016 | 12,374 |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | 04/29/2016 | 7,689 |
| MONTAGUE WILLIAM P | Director | 03/01/2016 | 143,994 |
| DE SILVA RAJIV | President & CEO | 03/18/2016 | 190,005 |
| DE SILVA RAJIV | President & CEO | 03/21/2016 | 836,788 |
| Spengler William | Director | 03/17/2016 | 29,200 |
| Spengler William | Director | 03/16/2016 | 35,240 |
| Hall Susan | EVP, CSO, Global Head of R&D | 03/11/2016 | 26,085 |
| KIMMEL ROGER H | Director | 03/11/2016 | 281,856 |
| KIMMEL ROGER H | Director | 03/14/2016 | 47,182 |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | 03/07/2016 | 22,240 |
| DE SILVA RAJIV | President & CEO | 03/07/2016 | 100,125 |
| Lortie Brian | President Branded Pharma | 03/02/2016 | 105,540 |
| DE SILVA RAJIV | President & CEO | 03/02/2016 | 2,419,886 |
| Spengler William | Director | 03/01/2016 | 143,994 |
| Smith Jill D. | Director | 03/01/2016 | 143,994 |
| HYATT MICHAEL | Director | 03/01/2016 | 143,994 |
| Hutson Nancy J | Director | 03/01/2016 | 143,994 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 02/26/2016 | 21,466 |
| Rudio Daniel | Vice President, Controller | 02/27/2016 | 15,441 |
| Rudio Daniel | Vice President, Controller | 02/26/2016 | 4,627 |
| Lortie Brian | President Branded Pharma | 02/27/2016 | 10,760 |
| Lortie Brian | President Branded Pharma | 02/26/2016 | 6,994 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 02/24/2016 | 34,546 |
| Rudio Daniel | Vice President, Controller | 02/24/2016 | 3,938 |
| Lortie Brian | President Branded Pharma | 02/24/2016 | 11,964 |
| Hall Susan | EVP, CSO, Global Head of R&D | 02/24/2016 | 11,914 |
| Lortie Brian | President Branded Pharma | 02/22/2016 | 15,464 |
| Rudio Daniel | Vice President, Controller | 02/22/2016 | 9,734 |
| KIMMEL ROGER H | Director | 11/16/2015 | 47,937 |
| KIMMEL ROGER H | Director | 11/11/2015 | 174,451 |
| Cooke Shane | Director | 11/12/2015 | 228,520 |
| Maletta Matthew Joseph | Exec. V.P.,Chief Legal Officer | 11/11/2015 | 28,095 |
| Lortie Brian | President Branded Pharma | 11/11/2015 | 39,529 |
| HYATT MICHAEL | Director | 11/11/2015 | 314,300 |
| HYATT MICHAEL | Director | 11/11/2015 | 443,840 |
| Hall Susan | EVP, CSO, Global Head of R&D | 11/11/2015 | 55,350 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 11/11/2015 | 250,856 |
| Campanelli Paul | President, Par Pharmaceutical | 11/11/2015 | 116,954 |
| DE SILVA RAJIV | President & CEO | 11/11/2015 | 500,013 |
| KIMMEL ROGER H | Director | 11/05/2015 | 539,100 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 09/24/2015 | 172,319 |
| HIGGINS ARTHUR J | Director | 06/16/2015 | 202,750 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 04/08/2015 | 3,105,904 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 04/07/2015 | 10,367 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 04/07/2015 | 46,226 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 04/08/2015 | 9,654,922 |
| Hall Susan | EVP, CSO, Global Head of R&D | 03/11/2015 | 55,989 |
| Farhat Camille | President, AMS, Inc. | 03/10/2015 | 773,223 |
| Farhat Camille | President, AMS, Inc. | 03/09/2015 | 1,297,806 |
| Farhat Camille | President, AMS, Inc. | 03/09/2015 | 3,518,915 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 03/05/2015 | 837,718 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 03/05/2015 | 3,689,657 |
| Lortie Brian | President Branded Pharma | 03/04/2015 | 495,030 |
| Rudio Daniel | Vice President, Controller | 02/27/2015 | 21,420 |
| Rudio Daniel | Vice President, Controller | 02/26/2015 | 6,900 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 02/27/2015 | 86,108 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 02/26/2015 | 51,881 |
| Farhat Camille | President, AMS, Inc. | 02/27/2015 | 30,040 |
| Farhat Camille | President, AMS, Inc. | 02/26/2015 | 55,544 |
| DeGolyer Donald W | Chief Operating Officer,Pharma | 02/26/2015 | 40,636 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 02/26/2015 | 34,246 |
| Rudio Daniel | Vice President, Controller | 02/23/2015 | 11,843 |
| Rudio Daniel | Vice President, Controller | 02/22/2015 | 16,378 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 02/22/2015 | 142,707 |
| MANOGUE CAROLINE B | Exec. V.P.,Chief Legal Officer | 02/23/2015 | 128,301 |
| DE SILVA RAJIV | President & CEO | 12/31/2014 | 455,188 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 11/14/2014 | 247,678 |
| KIMMEL ROGER H | Director | 10/14/2014 | 136,279 |
| Upadhyay Suketu | EVP, Chief Financial Officer | 09/24/2014 | 107,662 |
| Farhat Camille | President, AMS, Inc. | 09/05/2014 | 113,351 |
| HYATT MICHAEL | Director | 08/19/2014 | 220,600 |
| KIMMEL ROGER H | Director | 08/11/2014 | 220,600 |
| HIGGINS ARTHUR J | Director | 08/05/2014 | 229,775 |
| DeGolyer Donald W | Chief Operating Officer,Pharma | 08/02/2014 | 303,658 |
| DELUCCA JOHN | Director | 06/09/2014 | 166,597 |
| DELUCCA JOHN | Director | 06/09/2014 | 465,566 |
| MANOGUE CAROLINE B | Exec. V.P., CLO & Secy | 05/29/2014 | 4,398,608 |
| MANOGUE CAROLINE B | Exec. V.P., CLO & Secy | 05/29/2014 | 12,605,876 |
| DELUCCA JOHN | Director | 05/01/2014 | 192,799 |
| DELUCCA JOHN | Director | 05/01/2014 | 536,713 |
| DELUCCA JOHN | Director | 04/01/2014 | 174,451 |
| DELUCCA JOHN | Director | 04/01/2014 | 710,889 |
| Hutson Nancy J | Director | 03/10/2014 | 86,350 |
| Hutson Nancy J | Director | 03/10/2014 | 360,600 |
| HIGGINS ARTHUR J | Director | 03/10/2014 | 365,000 |
| Gergel Ivan P. | EVP, R&D and CSO | 03/10/2014 | 2,354,595 |
| Gergel Ivan P. | EVP, R&D and CSO | 03/10/2014 | 5,481,413 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ENDO INTERNATIONAL PLC
STOCK BUYBACKS FOR ENDO INTERNATIONAL PLC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
0.05%
1Q
06/30/2022
0.15%
2Q
03/31/2022
0.41%
3Q
12/31/2021
0.88%
4Q
09/30/2021
1.01%
5Q
06/30/2021
-0.93%
6Q
03/31/2021
-1.61%
7Q
12/31/2020
0.51%
8Q
09/30/2020
0.63%
9Q
06/30/2020
0.64%
10Q
03/31/2020
0.78%
11Q
12/31/2019
3.89%
12Q
09/30/2019
4.00%
13Q
06/30/2019
4.18%
14Q
03/31/2019
4.56%
15Q
12/31/2018
4.86%
16Q
Load More